Table 1 Classification criteria and stage groups by different systems for nasopharyngeal carcinoma
From: Comparison of TNM staging systems for nasopharyngeal carcinoma, and proposal of a new staging system
The 6th edition of UICC/AJCC | The 7th edition of UICC/AJCC | The Chinese 2008 staging system | The proposed staging system |
---|---|---|---|
T-classification | |||
T1: nasopharynx | T1: nasopharynx, oropharynx or nasal cavity | T1: nasopharynx | T1: nasopharynx |
T2a: oropharynx and/or nasal cavity T2b: parapharyneal extension | T2: parapharyneal extension | T2: oropharynx, nasal cavity, parapharyneal extension | T2: oropharynx, nasal cavity, parapharyneal extension, medial and lateral pterygoid muscles |
T3: bony structures and/or paranasal sinuses | T3: bony structures and/or paranasal sinuses | T3: skull base, medial pterygoid muscle extension | T3: bony structures and/or paranasal sinuses |
T4: intracranial extension and/or cranial nerves, infratemporal fossa hypopharynx, orbit or masticatory spacea | T4: intracranial extension and/or cranial nerves, hypopharynx, orbit or infratemporal fossa/masticatory spaceb | T4: cranial nerves, paranasal sinuses, masticatory space excluding medial pterygoid muscle, intracranial (cavernous sinus, dural meninges) extension | T4: intracranial extension and/or cranial nerves, infratemporal fossa hypopharynx, orbit or masticatory space excluding medial and lateral pterygoid muscles |
N-classification | |||
N0: none | N0: none | N0: none | N0: none |
N1: unilateral node(s), ⩽6 cm in greatest dimension, above the supraclavicular fossa | N1: unilateral cervical and/or unilateral or bilateral retropharyngeal node(s), ⩽6 cm in greatest dimension, above the supraclavicular fossa | N1a: retropharyngeal node(s) N1b: unilateral level Ib, II, III and Va involvement, and the maximum diameter ⩽3 cm | N1: unilateral or bilateral retropharyngeal node(s), unilateral level Ib, II, III, and Va involvement, and the maximum diameter ⩽3 cm |
N2: bilateral node(s), ⩽6 cm in greatest dimension, above the supraclavicular fossa | N2: bilateral cervical node(s), ⩽6 cm in greatest dimension, above the supraclavicular fossa | N2: bilateral level Ib, II, III and Va involvement, or the maximum diameter >3 cm, or with extranodal neoplastic spread | N2: bilateral level Ib, II, III and Va involvement, or the maximum diameter >3 cm, or with extranodal neoplastic spread |
N3a: >6 cm N3b: in supraclavicular fossa | N3a: >6 cm N3b: in supraclavicular fossa | N3: level IV and Vb involvement | N3: level IV and Vb involvement |
Stage group | |||
I: T1 N0 M0 | I: T1 N0 M0 | I: T1 N0 M0 | I: T1 N0 M0 |
IIa: T2a N0 M0 IIb: T1-2a N1 M0, T2b N0-1 M0 | II: T1 N1 M0, T2 N0-1 M0 | II: T1 N1a-1b M0, T2 N0-1b M0 | II: T1 N1 M0, T2 N0-1 M0 |
III: T1-2b N2 M0, T3 N0-2 M0 | III: T1-2 N2 M0, T3 N0-2 M0 | III: T1-2 N2 M0, T3 N0-2 M0 | III: T1-2 N2 M0, T3 N0-2 M0 |
IVa: T4 N0-2 M0 IVb: any T N3 M0 IVc: any T, any N M1 | IVa: T4 N0-2 M0 IVb: any T N3 M0 IVc: any T, any N M1 | IVa: T1-3N3M0, T4 N0-3 M0 IVb: any T, any N M1 | IVa: T1-3N3M0, T4 N0-3 M0 IVb: any T, any N M1 |